Artificial Intelligence for the Management of Breast Cancer: An Overview

Curr Drug Discov Technol. 2023 Dec 1. doi: 10.2174/0115701638262066231030052520. Online ahead of print.ABSTRACTBreast cancer is a severe global health problem, and early detection, accurate diagnosis, and personalized treatment is the key to improving patient outcomes. Artificial intelligence (AI) and machine learning (ML) have emerged as promising breast cancer research and clinical practice tools in recent years. Various projects are underway in early detection, diagnosis, prognosis, drug discovery, advanced image analysis, precision medicine, predictive modeling, and personalized treatment planning using artificial intelligence and machine learning. These projects use different algorithms, including convolutional neural networks (CNNs), support vector machines (SVMs), decision trees, and deep learning methods, to analyze and improve different types of data, such as clinical, genomic, and imaging data for breast cancer management. The success of these projects has the potential to transform breast cancer care, and continued research and development in this area is likely to lead to more accurate and personalized breast cancer diagnosis, treatment, and outcomes.PMID:38047362 | DOI:10.2174/0115701638262066231030052520
Source: Current Drug Discovery Technologies - Category: Drugs & Pharmacology Authors: Source Type: research